Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?, Crit Rev Oncog, vol.20, pp.155-171, 2015. ,
Ewing's sarcoma, Lancet Oncol, vol.11, pp.184-192, 2010. ,
Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data, J. Pediatr. Hematol. Oncol, vol.30, pp.425-430, 2008. ,
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration, J. Clin. Oncol, vol.33, pp.3036-3046, 2015. ,
Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group, Pediatr Blood Cancer, vol.63, pp.493-498, 2016. ,
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial, J. Clin. Oncol, vol.32, pp.2440-2448, 2014. ,
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group, J. Clin. Oncol, vol.30, pp.4148-4154, 2012. ,
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone, N. Engl. J. Med, vol.348, pp.694-701, 2003. ,
Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis, Cancer Epidemiol, vol.37, pp.29-33, 2013. ,
Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years, Cancer, vol.109, pp.780-786, 2007. ,
Treatment of adult patients with Ewing's sarcoma: compliance with chemotherapy protocols & toxicity, Med. Oncol, vol.28, issue.1, pp.685-689, 2011. ,
Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International, Clinical Trials EICESS, vol.92, pp.657-663, 2008. ,
Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients, J. Clin. Oncol, vol.16, pp.3736-3743, 1998. ,
Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease, Sarcoma, vol.2013, p.681425, 2013. ,
Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute, Am. J. Clin. Oncol, vol.11, pp.614-617, 1988. ,
Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome, Ann. Surg, vol.230, pp.79-86, 1999. ,
Treatment of patients aged over 50 years with non-osseous Ewing's sarcoma family tumors: five cases and review of literature, Tumori, vol.94, pp.809-812, 2008. ,
Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy, Cancer, vol.116, pp.3189-3194, 2010. ,
Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience, J. Pediatr. Hematol. Oncol, vol.37, pp.278-284, 2015. ,
Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group, J. Clin. Oncol, vol.18, pp.3108-3114, 2000. ,
Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database, Cancer Epidemiol, vol.39, pp.189-195, 2015. ,
Identification of Discrete Prognostic Groups in Ewing Sarcoma, Pediatr Blood Cancer, vol.63, pp.47-53, 2016. ,
Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry, Cancer, vol.116, pp.1964-1973, 2010. ,
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas, J. Clin. Oncol, vol.31, pp.608-615, 2013. ,
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future, Curr Opin Oncol, vol.20, pp.412-418, 2008. ,
Clinical features and outcomes in patients with extraskeletal Ewing sarcoma, Cancer, vol.117, pp.3027-3032, 2011. ,
Extraosseous localized ewing tumors: improved outcome with anthracyclines-the French society of pediatric oncology and international society of pediatric oncology, J. Clin. Oncol, vol.25, pp.1176-1182, 2007. ,
Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group, Pediatr Blood Cancer, 2016. ,
, , vol.7, 2017.
Survival after recurrence of Ewing's sarcoma family of tumors, J. Clin. Oncol, vol.23, pp.4354-4362, 2005. ,
Post-relapse survival in patients with Ewing sarcoma, Pediatr Blood Cancer, vol.62, pp.994-999, 2015. ,
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial, J. Clin. Oncol, vol.28, pp.3284-3291, 2010. ,
Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) compared to conventional chemotherapy combined with lung irradiation in ewing sarcoma (ES) with primary lung metastases: Results of EURO-EWING 99-R2pulm randomized trial (EE99R2pul), J. Clin. Oncol, vol.34 ,
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients, J. Clin. Oncol, vol.26, pp.4385-4393, 2008. ,
Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults, Bone Marrow Transplant, vol.50, pp.1083-1088, 2015. ,
High-dose Thiotepa as Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation for High-risk Ewing Family Tumors: Single-institution Experience, J. Pediatr. Hematol. Oncol, vol.37, pp.536-542, 2015. ,
Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) in localized high-risk Ewing sarcoma (ES): Results of EURO-EWING 99-R2 randomized trial ,
, J. Clin. Oncol, vol.34
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial, Pediatr Blood Cancer, vol.47, pp.22-29, 2006. ,
Age as an independent prognostic factor for survival of localised synovial sarcoma patients, Br. J. Cancer, vol.113, pp.1602-1606, 2015. ,
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes, Int J Mol Sci, vol.16, pp.16176-16215, 2015. ,
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations, Cancer Discov, vol.4, pp.1342-1353, 2014. ,